Indonesia vs Tajikistan: Average cost of tuberculosis treatment by type
Indonesia
17 constant 2022 US$
in 2024
Tajikistan
18 constant 2022 US$
in 2024
Indonesia rank
34th
Tajikistan rank
31st
Average cost of tuberculosis treatment by type over time
- Indonesia
- Tajikistan
How they compare
Tajikistan currently reports 18 constant 2022 US$ against 17 constant 2022 US$ in Indonesia, a difference of 1 constant 2022 US$.
That makes Tajikistan's figure about 1.1 times Indonesia's.
The two have swapped places 2 times across 6 shared years of data; in 2019 it was Tajikistan ahead.
Indonesia ranks 34th and Tajikistan ranks 31st of 62 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Tajikistan in 1.
Head to head by decade
| Decade | Indonesia | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5 constant 2022 US$ | 12 constant 2022 US$ | 7 constant 2022 US$ | Tajikistan |
| 2020s | 31 constant 2022 US$ | 24.8 constant 2022 US$ | 6.2 constant 2022 US$ | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Indonesia or Tajikistan?
- Tajikistan, at 18 constant 2022 US$ against 17 constant 2022 US$ in Indonesia as of 2024.
- What is the difference in average cost of tuberculosis treatment by type between Indonesia and Tajikistan?
- 1 constant 2022 US$, with Tajikistan ahead.
- How many years of comparable data are there for Indonesia and Tajikistan?
- 6 years are reported by both, from 2019 to 2024.
- How do Indonesia and Tajikistan rank globally for average cost of tuberculosis treatment by type?
- Indonesia ranks 34th and Tajikistan ranks 31st of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.